DIABETIC KETOACIDOSIS ASSOCIATED WITH EMPAGLIFLOZIN THERAPY : MECHANISMS, RISC FACTORS AND CLINICAL IMPLICATIONS. ijai. 2025;5(09):221-223. Accessed March 15, 2026. https://www.academicpublishers.org/journals/index.php/ijai/article/view/6299